The Procter & Gamble Company (PG) Stock Analysis 2026

Consumer DefensiveHousehold & Personal Products
$143.78
as of 2026-08-28

BriMind AI Score

Proprietary
40
Neutral
Price CAGR
7.6%
1Y Return
-8.8%
Analyst Upside
+11.0%
Rev Growth
1.5%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$148.63+3.4% potential
Bear Case
$111.58
Bull Case
$208.07
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

PG Revenue & Profitability Breakdown

This chart shows how PG's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$87.03B
Cost of Revenue
-$42.76B
Gross Profit
$44.28B50.9% margin
Operating Expenses
-$25.05B
Operating Income
$19.22B22.1% margin
Tax & Other
-$3.17B
Net Income
$16.05B18.4% margin
Gross Margin
50.9%
Operating Margin
22.1%
Net Margin
18.4%
EBITDA Margin
28.8%

Key Financial Metrics

The Procter & Gamble Company trades at a trailing P/E of 21.82x, generates $13.28B in free cash flow, runs a debt/equity ratio of 64.49, and converts shareholder equity into profit at a 30.3% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$336.30B
Enterprise Value
$410.63B
P/E (Trailing)
21.82
P/E (Forward)
19.56
EV / EBITDA
16.98
Price / Sales
4.58
Price / Book
7.47
Revenue
$87.03B
Revenue Growth
1.5%
Earnings Growth
-15.5%
EBITDA
$24.19B
Gross Margin
50.9%
Operating Margin
22.1%
Net Margin
18.4%
Return on Equity
30.3%
Return on Assets
10.7%
Free Cash Flow
$13.28B
Total Cash
$9.12B
Total Debt
$34.14B
Debt / Equity
64.49
Current Ratio
0.68
Quick Ratio
0.41
Beta
0.38
Dividend Yield
3.0%
Payout Ratio
64.3%
Book Value / Share
$22.95

The Procter & Gamble Company Valuation Context

21.8xTrailing P/E

The Procter & Gamble Company trades at 21.8x, which is 5% below the Consumer Defensive median of 22.9x.

Sector median computed live across 34 Consumer Defensive companies in our coverage universe with a positive trailing P/E. Forward P/E: 19.6x.

Wall Street Analyst Consensus

23 analysts covering The Procter & Gamble Company currently lean toward a Buy rating, with a mean 12-month price target of $160.57 (+11.7% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Consensus RatingBuy(23 analysts)
SellStrong Buy
Low Target$140.00-2.6%
Mean Target$160.57+11.7% upside
High Target$190.00+32.1%

Intrinsic Value Estimates for PG

We use 1 valuation model to estimate PG's intrinsic value. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

DCF Model (10yr)
$118.96
-17.3% vs current
Discounts 10 years of projected free cash flow back to today's dollars (5% growth, 10% discount rate). Best for companies generating consistent cash.
Fair Value Range
$118.96 – $118.96
Average Estimate
$118.96
Potential Downside
-17.3%

Intrinsic value estimates use simplified models (Graham, DCF, P/E) and conservative assumptions. They should be used as one input among many — not as sole buy/sell guidance. For advanced analysis, see the full platform.

Compare PG with Peers

PG vs CLProcter & Gamble vs Colgate — Which Consumer Staples St
CLX vs PGClorox vs Procter & Gamble — Niche Cleaner Brand vs Div
KO vs PGCoca-Cola vs Procter & Gamble — Which Dividend Aristocr
CL vs PGColgate-Palmolive vs P&G — Oral Care vs Diversified Con
KVUE vs PGKenvue vs Procter & Gamble — Consumer Health Spin-Off v
KMB vs PGKimberly-Clark vs Procter & Gamble — Which Household Gi

Unlock the Full PG Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis